- Home
- PRG vs CMPS Comparison
PRG vs CMPS Comparison
Compare PRG & CMPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRG | CMPS |
|---|---|---|
| Founded | 2020 | 2020 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | 2020 | 2020 |
Fundamental Metrics
Financial Performance| Metric | PRG | CMPS |
|---|---|---|
| Price | $38.52 | $12.08 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 8 |
| Target Price | ★ $50.00 | $25.38 |
| AVG Volume (30 Days) | 365.0K | ★ 4.0M |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.45% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.89 | N/A |
| Revenue | ★ $2,409,223,000.00 | N/A |
| Revenue This Year | $23.77 | N/A |
| Revenue Next Year | $7.91 | N/A |
| P/E Ratio | $41.72 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $25.80 | $2.25 |
| 52 Week High | $41.14 | $14.76 |
Technical Indicators
Market Signals| Indicator | PRG | CMPS |
|---|---|---|
| Relative Strength Index (RSI) | 63.12 | 56.69 |
| Support Level | $32.30 | $5.48 |
| Resistance Level | $38.57 | $14.76 |
| Average True Range (ATR) | 1.48 | 0.99 |
| MACD | 0.13 | -0.25 |
| Stochastic Oscillator | 77.00 | 35.33 |
Price Performance
Historical ComparisonAbout PRG PROG Holdings Inc.
PROG Holdings Inc is a financial technology holding company that provides transparent and competitive payment options to consumers. The company has two reportable segments: Progressive Leasing, an in-store, app-based, and e-commerce point-of-sale lease-to-own solutions provider; and Vive Financial (Vive), an omnichannel provider of second-look revolving credit products. The majority of the revenue of the company is earned through the Progressive Leasing segment.
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.